688553 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Sichuan Huiyu Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of pharmaceutical products. It offers anti-tumor injections such as pemetrexed disodium, azacitidine, docetaxel, zoledronic acid, doxorubicin hydrochloride, oxaliplatin, and epirubicin. The company was founded by Zhao Ding, Xiao Peng Wang and Bo Yu on October 12, 2010 and is headquartered in Neijiang, China.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
688553 has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company